Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001868286 | SCV002203404 | uncertain significance | Muscle AMP deaminase deficiency | 2023-11-10 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 631 of the AMPD1 protein (p.Leu631Phe). This variant is present in population databases (rs200717164, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with AMPD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 559257). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000676653 | SCV002817506 | uncertain significance | not provided | 2022-06-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV001868286 | SCV003826250 | uncertain significance | Muscle AMP deaminase deficiency | 2019-04-10 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676653 | SCV000802446 | uncertain significance | not provided | 2016-03-07 | no assertion criteria provided | clinical testing |